Coadministration of antigen-conjugated and free CpG: Effects of in vitro and in vivo interactions in a murine model

Melinda Herbáth, Zsuzsanna Szekeres, Dorottya Kövesdi, Krisztián Papp, Anna Erdei, József Prechl

Research output: Article

7 Citations (Scopus)


CpG oligodeoxynucleotides (CpG) are widely studied as promising adjuvants in vaccines against a range of diseases including infection, cancer or allergy. Conjugating antigen to CpG has been shown to potentiate the adjuvant effect via enhancing antigen uptake and danger signaling by the very same cell. In the present study, using biotinylated CpG and streptavidin as a model system, we demonstrate that CpG motif containing free and antigen-conjugated oligonucleotides do not compete in terms of cell activation via TLR9, but do compete for cellular uptake. Antigen-conjugated CpG enhances cellular association and uptake of the antigen by antigen-presenting cells (APC) and T cells. Free CpG efficiently competes with antigen-CpG conjugates in BMDC and T cells, but shows weak or no competition in B cells that have higher TLR9 expression. Vaccination with antigen-conjugated CpG or with a mixture of antigen and CpG elevates the level of antigen-specific antibodies but co-administration of CpG-antigen conjugates and free CpG adversely effects immunogenicity. These observations may help optimize CpG-based vaccine formulation.

Original languageEnglish
Pages (from-to)178-185
Number of pages8
JournalImmunology letters
Issue number2
Publication statusPublished - aug. 2014


ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this